Clinical Trials on Phenylketonurias in Colombia

Total 18 results

University of British Columbia
Rare Disease Foundation, Vancouver, Canada

Completed

Simple Breath Test to Examine Phenylalanine Metabolism

Phenylketonuria (PKU)

Canada
Washington University School of Medicine
University of Missouri-Columbia; Northwestern University; Oregon Health and Science... and other collaborators

Terminated

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults (165-901)

Phenylketonuria (PKU)

United States, Turkey, Canada, France, Germany, Italy, United Kingdom
BioMarin Pharmaceutical

Completed

Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU

Phenylketonuria (PKU)

United States
University of British Columbia
Vitaflo International, Ltd

Unknown

Protein Requirements in Adults With Phenylketonuria (PKU)

Phenylketonuria

Canada
University of British Columbia
Rare Disease Foundation, Vancouver, Canada; Saudi Arabian Cultural Bureau,...

Completed

Protein Requirements in Children With Phenylketonuria (PKU)

Phenylketonuria

Canada
University of Missouri-Columbia
BioMarin Pharmaceutical

Completed

The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU (Prism-2)

Phenylketonuria (PKU)

United States
University of Missouri-Columbia
BioMarin Pharmaceutical

Enrolling by invitation

Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU

Phenylketonurias

United States
Children's National Research Institute
Georgetown University

Withdrawn

Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria (PKU)

PKU

United States
University of Missouri-Columbia

Completed

Remote Neurocognitive and Psychological Assessment in PKU

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Phenylketonuria

United States, Canada
BioMarin Pharmaceutical

Completed

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry (PKUDOS)

Phenylketonuria | Hyperphenylalaninaemia

United States
BioMarin Pharmaceutical

Completed

Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU (PKU-015)

Phenylketonuria

United States, Canada
BioMarin Pharmaceutical

Completed

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 (Prism301)

Phenylketonuria

United States
BioMarin Pharmaceutical

Approved for marketing

Sapropterin Expanded Access Program

Phenylketonuria

United States

Clinical Trials on Phenylketonurias in Colombia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations